NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/11/2025
Back to search
Official data from USPTO
PHARMATEK LABORATORIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMATEK LABORATORIES
ST13
US500000076105400Class
42
Filing
76105400
Registration
2920287
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/02/2025
Trademark type
Word
Nice classes
42
Filing date
08/08/2000
Registration date
01/25/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/19/1999
First use in commerce
04/19/1999
Drawing code
1
Owner type
03
Owner location
San Diego, CA
Examiner
ENGEL, MICHAEL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pharmatek Laboratories, Inc.
Representatives
Vanessa A. Ignacio, Esq. Lowenstein Sandler, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical product development that identifies compatible oral formulations for new drug candidatesapplying physiochemical evaluation techniques to traditional and state of the art pharmaceutical excipients using a compatability matrix
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/11/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/24/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/25/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/25/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/22/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/22/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/23/2016
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/20/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/20/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/20/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/20/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
07/27/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/13/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/01/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/01/2010
E815
TEAS SECTION 8 & 15 RECEIVED
01/25/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/26/2006
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/26/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2005
PUBO
PUBLISHED FOR OPPOSITION
11/02/2004
NPUB
NOTICE OF PUBLICATION
10/13/2004
CFIT
CASE FILE IN TICRS
09/02/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2002
CNEA
EXAMINERS AMENDMENT MAILED
10/23/2002
CNSL
LETTER OF SUSPENSION MAILED
03/19/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2001
CNRT
NON-FINAL ACTION MAILED
02/09/2001
DOCK
ASSIGNED TO EXAMINER
02/06/2001
Continuous trademark protection
Get notified about every new filing that threatens PHARMATEK LABORATORIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.